Culture

Protein tells developing cells to stick together

image: Compartments in adult tissues. Fluorescent protein expression shows posterior compartments in the wing and the abdomen. Please notice that boundaries between compartments are amazingly straight.

Image: 
Tohoku University

Tohoku University scientists have, for the first time, provided experimental evidence that cell stickiness helps them stay sorted within correct compartments during development. How tightly cells clump together, known as cell adhesion, appears to be enabled by a protein better known for its role in the immune system. The findings were detailed in the journal Nature Communications.

Scientists have long observed that not-yet-specialized cells move in a way that ensures that cell groups destined for a specific tissue stay together. In 1964, American biologist Malcolm Steinberg proposed that cells with similar adhesiveness move to come in contact with each other to minimize energy use, producing a thermodynamically stable structure. This is known as the differential adhesion hypothesis.

"Many other theoretical works have emphasized the importance of differences in cell-to-cell adhesion for separating cell populations and maintaining the boundaries between them, but this had not yet been demonstrated in living animal epithelial tissues," says Erina Kuranaga of Tohoku University's Laboratory for Histogenetic Dynamics, who led the investigations. "Our study showed, for the first time, that cell sorting is regulated by changes in adhesion."

Kuranaga and her team conducted experiments in fruit fly pupae, finding that a gene, called Toll-1, played a major role in this adhesion process.

As fruit flies develop from the immature larval stage into the mature adult, epithelial tissue-forming cells, called histoblasts, cluster together into several 'nests' in the abdomen. Each nest contains an anterior and a posterior compartment. Histoblasts are destined to replace larval cells to form the adult epidermis, the outermost layer that covers the flies. The cells in each compartment form discrete cell populations, so they need to stick together, with a distinct boundary forming between them.

Using fluorescent tags, Kuranaga and her team observed the Toll-1 protein is expressed mainly in the posterior compartment. Its fluorescence also showed a sharp boundary between the two compartments.

Further investigations showed Toll-1 performs the function of an adhesion molecule, encouraging similar cells to stick together. This process keeps the boundary between the two compartments straight, correcting distortions that arise as the cells divide to increase the number.

Interestingly, Toll proteins are best known for recognizing invading pathogens, and little is known about their work beyond the immune system. "Our work improves understanding of the non-immune roles of Toll proteins," says Kuranaga. She and her team next plan to study the function of other Toll genes in fruit fly epithelial cells.

Credit: 
Tohoku University

Modeling can help balance economy, health during pandemic

image: Arye Nehorai, the Eugene & Martha Lohman Professor of Electrical Engineering in the Preston M. Green Department of Electrical & Systems Engineering

Image: 
Washington University in St. Louis

This summer, when bars and restaurants and stores began to reopen across the United States, people headed out despite the continuing threat of COVID-19.

As a result, many areas, including the St. Louis region, saw increases in cases in July.

Using mathematical modeling, new interdisciplinary research from the lab of Arye Nehorai, the Eugene & Martha Lohman Professor of Electrical Engineering in the Preston M. Green Department of Electrical & Systems Engineering at Washington University in St. Louis, determines the best course of action when it comes to walking the line between economic stability and the best possible health outcomes.

The group -- which also includes David Schwartzman, a business economics PhD candidate at Olin Business School, and Uri Goldsztejn, a PhD candidate in biomedical engineering at the McKelvey School of Engineering -- published their findings Dec. 22 in PLOS ONE.

The model indicates that of the scenarios they consider, communities could maximize economic productivity and minimize disease transmission if, until a vaccine were readily available, seniors mostly remained at home while younger people gradually returned to the workforce.

"We have developed a predictive model for COVID-19 that considers, for the first time, its intercoupled effect on both economic and health outcomes for different quarantine policies," Nehorai said. "You can have an optimal quarantine policy that minimizes the effect both on health and on the economy."

The work was an expanded version of a Susceptible, Exposed, Infectious, Recovered (SEIR) model, a commonly used mathematical tool for predicting the spread of infections. This dynamic model allows for people to be moved between groups known as compartments, and for each compartment to influence the other in turn.

At their most basic, these models divide the population into four compartments: Those who are susceptible, exposed, infectious and recovered. In an innovation to this traditional model, Nehorai's team included infected but asymptomatic people as well, taking into account the most up-to-date understanding of how transmission may work differently between them as well as how their behaviors might differ from people with symptoms. This turned out to be highly influential in the model's outcomes.

People were then divided into different "sub-compartments," for example age (seniors are those older than 60), or by productivity. This was a measure of a person's ability to work from home in the case of quarantine measures. To do this, they looked at college degrees as a proxy for who could continue to work during a period of quarantine.

Then they got to work, developing equations which modeled the ways in which people moved from one compartment to another. Movement was affected by policy as well as the decisions an individual made.

Interestingly, the model included a dynamic mortality rate - one that shrunk over time. "We had a mortality rate that accounted for improvements in medical knowledge over time," said Uri Goldsztejn, a PhD candidate in biomedical engineering. "And we see that now; mortality rates have gone down."

"For example," Goldsztejn said, "if the economy is decreasing, there is more incentive to leave quarantine," which might show up in the model as people moving from the isolated compartment to the susceptible compartment. On the other hand, moving from infectious to recovered was based less on a person's actions and can be better determined by recovery or mortality rates. Additionally, the researchers modeled the mortality rate as decreasing over time, due to medical knowledge about how to treat COVID-19 becoming better over time.

The team looked at three scenarios, according to Schwartzman. In all three scenarios, the given timeline was 76 weeks -- at which time it assumed a vaccine would be available -- and seniors remained mostly quarantined until then.

If strict isolation measures were maintained throughout.
If, after the curve was flattened, there was a rapid relaxation of isolation measures by younger people to normal movement.

If, after the curve was flattened, isolation measures were slowly lifted for younger people.

"The third scenario is the case which was the best in terms of economic damage and health outcomes," he said. "Because in the rapid relaxation scenario, there was another disease spread and restrictions would be reinstated."

Specifically, they found in the first scenario, there are 235,724 deaths and the economy shrinks by 34%.

In the second scenario, where there was a rapid relaxation of isolation measures, a second outbreak occurs for a total of 525,558 deaths, and the economy shrinks by 32.2%.

With a gradual relaxation, as in the third scenario, there are 262,917 deaths, and the economy shrinks by 29.8%.

"We wanted to show there is a tradeoff," Nehorai said. "And we wanted to find, mathematically, where is the sweet spot?" As with so many things, the "sweet spot" was not at either extreme -- total lockdown or carrying on as if there was no virus.

Another key finding was one no one should be surprised to hear: "People's' sensitivity to contagiousness is related to the precautions they take," Nehorai said. "It's still critical to use precautions -- masks, social distancing, avoiding crowds and washing hands."

Credit: 
Washington University in St. Louis

Common diabetes drug may trigger rare complications for COVID-19 patients

Diabetes is a known risk factor for morbidity and mortality related to COVID-19. In diabetes patients, rare but severe complications, like the potentially lethal condition diabetic ketoacidosis (DKA), can arise when illness or certain conditions prevent cells from receiving enough glucose to fuel their functioning. An uptick in a particular type of DKA called euDKA at Brigham and Women's Hospital during the COVID-19 pandemic has led researchers to hypothesize that diabetes patients on glucose-lowering drugs may be at increased risk for euDKA when they contract COVID-19. The observational case series was published in The American Association of Clinical Endocrinologists Clinical Case Reports.

EuDKA is a subset of the diabetes complication known as DKA, which occurs when the body's cells fail to absorb enough glucose and compensate by metabolizing fats instead, creating a build-up of acids called ketones. EuDKA differs from DKA in that it is characterized by lower blood sugar levels, making it more difficult to diagnose. The U.S. Food and Drug Administration has warned that the risk of DKA and euDKA may be increased for individuals who use a popular class of diabetes drugs called sodium-glucose cotransporter 2 inhibitors (SGLT2i), which function by releasing excess glucose in the urine. Underlying nearly all euDKA cases is a state of starvation that can be triggered by illnesses that cause vomiting, diarrhea, and loss of appetite and can be compounded by the diuretic effect of SGLT2i drugs.

Brigham researchers studied five unusual euDKA cases brought to the diabetes inpatient services within the span of two months, three of which occurred in one week, at the height of the pandemic in Boston in the spring of 2020. The five cases represented a markedly heightened incidence of euDKA compared to that of the previous two years, when inpatient services saw fewer than 10 euDKA cases. All five of the recent euDKA cases were observed in COVID-19 patients who were taking SGLT2i; three patients were discharged to rehabilitation facilities, one was discharged home, and one, a 52-year-old male with acute respiratory distress syndrome, died.

"We have the background knowledge of recognizing that SGLT2 inhibitors can cause DKA and euDKA," said corresponding author Naomi Fisher of the Division of Endocrinology, Diabetes, and Hypertension. "Our report reinforces that if patients are ill or have loss of appetite or are fasting, they should pause their medication and not resume until they are well and eating properly."

The authors of the study also suspect that COVID-19 may particularly exacerbate euDKA risks. When the virus infects a patient, it binds to cells on the pancreas that produce insulin and may exert a toxic effect on them. Studies of the earlier SARS-CoV-1 virus found that many infected patients had increased blood sugar. "It's been posited through other models that the virus may be preferentially destroying insulin-producing cells," Fisher said.

Moreover, the maladaptive inflammatory response associated with COVID-19, which produces high levels of immune-response-related proteins called cytokines, may increase DKA risks. "These high levels of cytokines are also seen in DKA, so these inflammatory pathways may be interacting," Fisher said. "It's speculative, but there may be some synergy between them."

Though these findings are observational, rather than the results of a randomized controlled trial, similar reports of heightened euDKA incidence have emerged from other institutions. The authors encourage patients and physicians to halt SGLT2i-use in the event of illness, which is already standard practice for the most common diabetes drug, metformin.

"Patients should continue to monitor their blood sugar, and if the illness is prolonged or if their blood sugar is very high, they can speak to their doctor about other forms of therapy," Fisher said. "But often it's a very short course off of the drug. We're hopeful that with widespread patient and physician education, we will not see another cluster of euDKA cases amid the next surge in COVID-19 infections."

Credit: 
Brigham and Women's Hospital

COVID-19 severity affected by proportion of antibodies targeting crucial viral protein

COVID-19 antibodies preferentially target a different part of the virus in mild cases of COVID-19 than they do in severe cases, and wane significantly within several months of infection, according to a new study by researchers at Stanford Medicine.

The findings identify new links between the course of the disease and a patient's immune response. They also raise concerns about whether people can be re-infected, whether antibody tests to detect prior infection may underestimate the breadth of the pandemic and whether vaccinations may need to be repeated at regular intervals to maintain a protective immune response.

"This is one of the most comprehensive studies to date of the antibody immune response to SARS-CoV-2 in people across the entire spectrum of disease severity, from asymptomatic to fatal," said Scott Boyd, MD, PhD, associate professor of pathology. "We assessed multiple time points and sample types, and also analyzed levels of viral RNA in patient nasopharyngeal swabs and blood samples. It's one of the first big-picture looks at this illness."

The study found that people with severe COVID-19 have low proportions of antibodies targeting the spike protein used by the virus to enter human cells compared with the number of antibodies targeting proteins of the virus's inner shell.

Boyd is a senior author of the study, which was published Dec. 7 in Science Immunology. Other senior authors are Benjamin Pinsky, MD, PhD, associate professor of pathology, and Peter Kim, PhD, the Virginia and D. K. Ludwig Professor of Biochemistry. The lead authors are research scientist Katharina Röltgen, PhD; postdoctoral scholars Abigail Powell, PhD, and Oliver Wirz, PhD; and clinical instructor Bryan Stevens, MD.

Virus binds to ACE2 receptor

The researchers studied 254 people with asymptomatic, mild or severe COVID-19 who were identified either through routine testing or occupational health screening at Stanford Health Care or who came to a Stanford Health Care clinic with symptoms of COVID-19. Of the people with symptoms, 25 were treated as outpatients, 42 were hospitalized outside the intensive care unit and 37 were treated in the intensive care unit. Twenty-five people in the study died of the disease.

SARS-CoV-2 binds to human cells via a structure on its surface called the spike protein. This protein binds to a receptor on human cells called ACE2. The binding allows the virus to enter and infect the cell. Once inside, the virus sheds its outer coat to reveal an inner shell encasing its genetic material. Soon, the virus co-opts the cell's protein-making machinery to churn out more viral particles, which are then released to infect other cells.

Antibodies that recognize and bind to the spike protein block its ability to bind to ACE2, preventing the virus from infecting the cells, whereas antibodies that recognize other viral components are unlikely to prevent viral spread. Current vaccine candidates use portions of the spike protein to stimulate an immune response.

Boyd and his colleagues analyzed the levels of three types of antibodies -- IgG, IgM and IgA -- and the proportions that targeted the viral spike protein or the virus's inner shell as the disease progressed and patients either recovered or grew sicker. They also measured the levels of viral genetic material in nasopharyngeal samples and blood from the patients. Finally, they assessed the effectiveness of the antibodies in preventing the spike protein from binding to ACE2 in a laboratory dish.

"Although previous studies have assessed the overall antibody response to infection, we compared the viral proteins targeted by these antibodies," Boyd said. "We found that the severity of the illness correlates with the ratio of antibodies recognizing domains of the spike protein compared with other nonprotective viral targets. Those people with mild illness tended to have a higher proportion of anti-spike antibodies, and those who died from their disease had more antibodies that recognized other parts of the virus."

Substantial variability in immune response

The researchers caution, however, that although the study identified trends among a group of patients, there is still substantial variability in the immune response mounted by individual patients, particularly those with severe disease.

"Antibody responses are not likely to be the sole determinant of someone's outcome," Boyd said. "Among people with severe disease, some die and some recover. Some of these patients mount a vigorous immune response, and others have a more moderate response. So, there are a lot of other things going on. There are also other branches of the immune system involved. It's important to note that our results identify correlations but don't prove causation."

As in other studies, the researchers found that people with asymptomatic and mild illness had lower levels of antibodies overall than did those with severe disease. After recovery, the levels of IgM and IgA decreased steadily to low or undetectable levels in most patients over a period of about one to four months after symptom onset or estimated infection date, and IgG levels dropped significantly.

"This is quite consistent with what has been seen with other coronaviruses that regularly circulate in our communities to cause the common cold," Boyd said. "It's not uncommon for someone to get re-infected within a year or sometimes sooner. It remains to be seen whether the immune response to SARS-CoV-2 vaccination is stronger, or persists longer, than that caused by natural infection. It's quite possible it could be better. But there are a lot of questions that still need to be answered."

Boyd is a co-chair of the National Cancer Institute's SeroNet Serological Sciences Network, one of the nation's largest coordinated research efforts to study the immune response to COVID-19. He is the principal investigator of Center of Excellence in SeroNet at Stanford, which is tackling critical questions about the mechanisms and duration of immunity to SARS-CoV-2.

"For example, if someone has already been infected, should they get the vaccine? If so, how should they be prioritized?" Boyd said. "How can we adapt seroprevalence studies in vaccinated populations? How will immunity from vaccination differ from that caused by natural infection? And how long might a vaccine be protective? These are all very interesting, important questions."

Credit: 
Stanford Medicine

Remarkable new species of snake found hidden in a biodiversity collection

image: Jeff Weinell, a KU graduate research assistant at the Biodiversity Institute, is lead author of a paper describing Waray Dwarf Burrowing Snake as both a new genus and a new species, in the peer-reviewed journal Copeia.

Image: 
University of Kansas

LAWRENCE -- To be fair, the newly described Waray Dwarf Burrowing Snake (Levitonius mirus) is pretty great at hiding.

In its native habitat, Samar and Leyte islands in the Philippines, the snake spends most of its time burrowing underground, usually surfacing only after heavy rains in much the same way earthworms tend to wash up on suburban sidewalks after a downpour.

So, it may not be shocking that when examples of the Waray Dwarf Burrowing Snake were collected in 2006 and 2007, they were misidentified in the field -- nobody had seen them before. The specimens spent years preserved in the collections of the University of Kansas Biodiversity Institute and Natural History Museum, overlooked by researchers who were unaware they possessed an entirely new genus of snake, even after further examples were found in 2014.

But that changed once Jeff Weinell, a KU graduate research assistant at the Biodiversity Institute, took a closer look at the specimens' genetics using molecular analysis, then sent them to collaborators at the University of Florida for CT scanning. Now, he's the lead author on a paper describing the snake as both a new genus, and a new species, in the peer-reviewed journal Copeia.

"I was initially interested in studying the group of snakes that I thought it belonged to -- or that other people thought it belonged to," Weinell said. "This is when I first started my Ph.D. at KU. I was interested in collecting data on a lot of different snakes and finding out what I actually wanted to research. I knew this other group of small, burrowing snakes called Pseudorabdion -- there are quite a few species in the Philippines -- and I was interested in understanding the relationships among those snakes. So, I made a list of all the specimens we had in the museum of that group, and I started sequencing DNA for the tissues that were available."

As soon as Weinell got the molecular data back, he realized the sample from the subterranean snake didn't fall within Pseudorabdion. But pinpointing where the snake should be classified wasn't a simple task: The Philippine archipelago is an exceptionally biodiverse region that includes at least 112 species of land snakes from 41 genera and 12 families.

"It was supposed to be closely related, but it was actually related to this entirely different family of snakes," he said. "That led me to look at it in more detail, and I realized that there were actually some features that were quite different from what it was initially identified as."

Working with Rafe Brown, professor of ecology & evolutionary biology and curator-in-charge of the KU Biodiversity Institute and Natural History Museum, Weinell took a closer look at the snake's morphology, paying special attention to the scales on the body, which can be used to differentiate species.

He then sent one of the specimens to the University of Florida for CT scanning to get a more precise look at the internal anatomy of the mysterious Philippine snake. The CT images turned out to be surprising.

"The snake has among the fewest number of vertebrae of any snake species in the world, which is likely the result of miniaturization and an adaptation for spending most of its life underground," Weinell said.

Finally, the KU graduate research assistant and his colleagues were able to determine the Waray Dwarf Burrowing Snake mirus was a new "miniaturized genus" and species of snake. Now, for the first time, Weinell has had the chance to bestow the snake with its scientific name, Levitonius mirus.

"It's actually named for Alan Leviton, who is a researcher at the California Academy of Sciences, and he had spent decades basically studying snakes in the Philippines in the '60s, '70s, '80s and then all the way up to now," Weinell said. "So, that's sort of an honorific genus name for him. Then, 'mirus' is Latin for unexpected. That's referencing the unexpected nature of this discovery -- getting the DNA sequences back and then wondering what was going on."

In addition to Brown, Weinell's co-authors on the new paper are Daniel Paluh of the University of Florida and Cameron Siler of the University of Oklahoma. Brown said the description of Levitonius mirus highlights the value of preserving collections of biodiversity in research institutions and universities.

"In this case, the trained 'expert field biologists' misidentified specimens -- and we did so repeatedly, over years -- failing to recognize the significance of our finds, which were preserved and assumed to be somewhat unremarkable, nondescript juveniles of common snakes," Brown said. "This happens a lot in the real world of biodiversity discovery. It was only much later, when the next generation of scientists came along and had the time and access to accumulated numbers of specimens, and when the right people, like Jeff, who asked the right questions and who had the right tools and expertise, like Dan, came along and took a fresh look, that we were able to identify this snake correctly. It's a good thing we have biodiversity repositories and take our specimen-care oaths seriously."

According to Marites Bonachita-Sanguila, a biologist at the Biodiversity Informatics and Research Center at Father Saturnino Urios University, located in the southern Philippines, the snake discovery "tells us that there is still so much more to learn about reptile biodiversity of the southern Philippines by focusing intently on species-preferred microhabitats."

"The pioneering Philippine herpetological work of Walter Brown and Angel Alcala from the 1960s to the 1990s taught biologists the important lesson of focusing on species' very specific microhabitat preferences," Bonachita-Sanguila said. "Even so, biologists have really missed many important species occurrences, such as this, because .... well, simply because we did not know basic clues about where to find them. In the case of this discovery, the information that biologists lacked was that we should dig for them when we survey forests. So simple. How did we miss that? All this time, we were literally walking on top of them as we surveyed the forests of Samar and Leyte. Next time, bring a shovel."

She added that habitat loss as a result of human-mediated land use (such as conversion of forested habitats for agriculture to produce food for people) is a prevailing issue in Philippine society today.

"This new information, and what we will learn more in future studies of this remarkable little creature, would inform planning for conservation action, in the strong need for initiatives to conserve Philippine endemic species -- even ones we seldom get to see," Bonachita-Sanguila said. "We need effective land-use management strategies, not only for the conservation of celebrated Philippine species like eagles and tarsiers, but for lesser-known, inconspicuous species and their very specific habitats -- in this case, forest-floor soil, because it's the only home they have."

Credit: 
University of Kansas

Neurology patients faced with rising out-of-pocket costs for tests, office visits

MINNEAPOLIS - Just like with drug costs, the amount of money people pay out-of-pocket for diagnostic tests and office visits for neurologic conditions has risen over 15 years, according to a new study published in the December 23, 2020, online issue of issue of Neurology®, the medical journal of the American Academy of Neurology. The study, funded by the American Academy of Neurology, found that people enrolled in high-deductible health plans were more likely to have high out-of-pocket costs than people in other types of plans.

"This trend of increased out-of-pocket costs could be harmful, as people may forgo diagnostic evaluation due to costs, or those who complete diagnostic testing may be put in a position of financial hardship before they can even start to treat their condition," said study author Chloe E. Hill, MD, MS, of the University of Michigan in Ann Arbor and a member of the American Academy of Neurology. "What's more, right now neurologists and patients may not have individualized information available regarding what the out-of-pocket costs might be to make informed decisions about use of care."

For the study, researchers examined out-of-pocket costs for visits to a neurologist and diagnostic tests ordered by a neurologist over a 15-year period using a large private insurance claims database. Costs for more than 3.7 million people were included.

The study found an increasing number of people were paying out-of-pocket costs for diagnostic tests and office visits over the years. The out-of-pocket costs are rising and vary greatly across patients and tests, Hill said.

For patients who had out-of-pocket costs for diagnostic tests, average inflation-adjusted out-of-pocket costs rose by as much as 190% over the study period. Average out-of-pocket costs for electroencephalogram (EEG) tests, which can be used to diagnose conditions such as epilepsy, increased from $39 to $112. For MRI scans, they increased from $84 to $242. Office visits increased from an average of $18 to $52.

Including both tests and office visits, people who paid out-of-pocket costs paid on average an increasing amount of the total cost of the service. For example, people paid on average 7% of the cost of an MRI scan at the beginning of the study, compared to 15% of the cost by the end of the study.

The percentage of people who paid out-of-pocket costs for tests varied by test, but all increased over the years. For MRIs, 24% of people paid out of pocket in 2001, compared to 70% in 2016.

People with high-deductible health plans were more likely to have out-of-pocket costs on tests and to have higher out-of-pocket costs. In 2001, none of the people in the study were enrolled in high-deductible health plans. By 2016, 11% of people were enrolled in these plans.

The researchers also found that out-of-pocket costs varied considerably. For an MRI in 2016, the people paying the median amount paid $103, while the people with the top 5% of costs paid $875.

"This study adds further weight to earlier studies from the American Academy of Neurology showing that out-of-pocket costs for neurologic medications are rising sharply, making people less likely to take their medications as often as their doctors prescribed," said James C. Stevens, MD, FAAN, President of the American Academy of Neurology. "Costs have risen to the point where systematic changes are needed. These changes could include legislative action to place a cap on out-of-pocket costs. The American Academy of Neurology is advocating for such caps on out-of-pocket drug costs in Washington, D.C."

A limitation of the study is that costs were examined for only one insurer, so the results may not reflect other private insurers or Medicaid.

Credit: 
American Academy of Neurology

People in rural areas less likely to receive specialty care for neurologic conditions

MINNEAPOLIS - A new study has found that while the prevalence of neurologic conditions like dementia, stroke, Parkinson's disease and multiple sclerosis (MS) is consistent across the U.S., the distribution of neurologists is not, and people in more rural areas may be less likely to receive specialty care for certain neurologic conditions. The study, funded by the American Academy of Neurology, is published in the December 23, 2020, online issue of Neurology®, the medical journal of the American Academy of Neurology.

"Neurologists in the United States are not evenly spread out, which affects whether patients can see a neurologist for certain conditions like dementia and stroke," said study author Brian C. Callaghan, MD, MS, of the University of Michigan in Ann Arbor and a Fellow of the American Academy of Neurology. "Our research found that some areas of the country have up to four times as many neurologists as the lowest served areas, and these differences mean that some people do not have access to neurologists who are specially trained in treating brain diseases."

However, Callaghan noted that the proportion of people receiving specialty care from a neurologist in more rural areas varied by condition. People with specific, less common conditions such as Parkinson's disease and multiple sclerosis were just as likely to see a neurologist in more rural areas as in more urban areas, while people with less specific neurologic symptoms that are more common, such as dementia, pain, dizziness or vertigo or sleep disorders, were more likely to see a neurologist in more urban areas than in more rural areas.

For the study, researchers reviewed one year of data for 20% of people enrolled in Medicare and identified 2.1 million people with at least one office visit for a neurologic condition.

Researchers recorded the number of times people had an office visit with a neurologist during that year and compared that to how many times people had office visits with other health care providers for a neurologic condition.

Researchers identified a total of 13,627 neurologists practicing in the regions where study participants lived.

Researchers found the areas with the fewest neurologists had an average of 10 neurologists for every 100,000 people, while the areas with the most neurologists had an average of 43 neurologists for every 100,000 people.

Researchers also found that the prevalence of neurologic conditions was not different across regions. Nearly one-third of people had at least one office visit for a neurologic condition.

Overall, 24% of people with a neurologic condition were seen by a neurologist. In more rural areas, this number was 21%, compared to 27% in the areas with the most neurologists. Most of that difference was made up of people with dementia, back pain and stroke. For dementia, 38% of people in more rural areas saw a neurologist, compared to 47% in more urban areas. For stroke, 21% of people in more rural areas saw a neurologist, compared to 31% in more urban areas.

On the other hand, more than 80% of people with Parkinson's disease received care from a neurologist, no matter where they lived. The numbers were similar for multiple sclerosis.

"It is important that all people have access to the best neurologic care," said James C. Stevens, MD, FAAN, President of the American Academy of Neurology. "Not surprisingly, more neurologists tend to work and live in metropolitan areas, but this study underlines the need to ensure that rural areas also have a supply of neurologists to meet demand. One way to give people more access to neurologic care is with telemedicine, which has been used successfully during the COVID-19 pandemic. Remote office visits by computer or telephone are one way to extend neurological service to people in underserved areas."

A limitation of the study is that researchers looked at neurologic visits only for people with Medicare coverage, so results may not be applicable to younger people with private insurance.

Credit: 
American Academy of Neurology

New research highlights the importance of the thymus in successful pregnancies

image: Magdalena Paolino, assistant professor and team leader at the Department of Medicine Solna, Karolinska Institutet.

Image: 
Ragnar Söderberg Foundation

How the immune system adapts to pregnancies has puzzled scientists for decades. Now, findings from an international group of researchers, led by researchers at Karolinska Institutet in Sweden, reveal important changes that occur in the thymus to prevent miscarriages and gestational diabetes. The results are published in the journal Nature.

The thymus is a central organ of the immune system where specialised immune cells called T lymphocytes mature. These cells, commonly referred to as T cells, then migrate into the blood stream and tissues to help combat pathogens and cancer. An important T cell subset, known as a regulatory T cell or Treg, is also produced in the thymus. The main function of a Treg is to help regulate other immune cells.

In the study, the researchers have found that during pregnancy, the female sex hormones instruct the thymus to produce Tregs specialised in dealing with physiological changes during pregnancy. The study--which involved researchers at Karolinska Institutet, IMBA - the Institute of Molecular Biotechnology of the Austrian Academy of Sciences in Vienna and the University of British Columbia in Vancouver--further reveals that RANK, a receptor expressed in the thymus epithelia, is the key molecule behind this mechanism.

"We knew RANK was expressed in the thymus, but its role in pregnancy was unknown", says first and co-corresponding author Dr. Magdalena Paolino, assistant professor and team leader at the Department of Medicine, Solna, Karolinska Institutet.

To get a better understanding, the authors studied mice where RANK had been deleted from the thymus.

"The absence of RANK prevented the production of Tregs in the thymus during pregnancy. This resulted in less Tregs in the placentas, leading to miscarriages," continues Magdalena Paolino.

The study further shows that in normal pregnancies, the produced Tregs also migrate to the mother's fat tissue to prevent inflammation and help control glucose levels in the body. Pregnant mice lacking RANK had high levels of glucose and insulin in their blood and many other indicators of gestational diabetes, including fetal macrosomia.

"Similar to babies of women with gestational diabetes, the newborn pups were much heavier than average," explains Magdalena Paolino.

In addition, the deficiency of Tregs during pregnancy was proven to result in long-lasting transgenerational effects on the offspring, which remained prone to diabetes and overweight throughout their life spans. Giving the RANK deficient mice thymus-derived Tregs that had been isolated from normal pregnancies, reversed all issues including fetal loss and maternal glucose levels and the body weights of the pups.

The researchers also analysed women with gestational diabetes, revealing a reduced number of Tregs in their placentas, much similar to the study on mice.

"This research changes our view of the thymus, as an active and dynamic organ required to safeguard pregnancies," Magdalena Paolino says. "It also provides new molecular insight for gestational diabetes, a disease that affects many women and which we still know little about. It emphasises the importance of clinics detecting and managing glucose metabolism in pregnant women to avert its long-term effects."

Co-corresponding author Dr. Josef Penninger notes that how rewiring of the thymus contributes to a healthy pregnancy was one of the remaining mysteries of immunology - until now.

"Our work over many years has now not only solved this puzzle - pregnancy hormones rewire the thymus via RANK - but uncovered a new paradigmatic function: the thymus not only changes the immune system of the mother to allow the fetus, but it also controls metabolic health of the mother," Josef Penninger says.

Credit: 
Karolinska Institutet

Weedy Seadragon genomics reveal highly distinct populations

Charismatic, iconic and Instagram-friendly, the weedy seadragon is a favourite with divers and snorkellers. The first genomic study of east coast Australian seadragon populations can now reveal "weedies" from NSW, Victoria and Tasmania are significantly different.

The study, published in PLOS ONE, also reveals that Victorian weedy seadragons may form a subspecies which has implications for conservation management. The researchers recommend that, as a precautionary approach, these distinct populations be managed separately by each state.

Lead investigator Dr Selma Klanten, from the University of Technology Sydney (UTS) Fish Ecology Laboratory, said that despite the public popularity of these fish few scientific studies exist.

"The research aimed to understand the genetic structure and diversity of weedy seadragon populations along Australia's east coast," Dr Klanten said.

"This is important because like all sygnathids, seadragons are endemic to temperate Australia. As adults they might only move 50-500 metres away from where they were born. This can make them susceptible to loss of habitat and changing environmental conditions.

"Although 'weedies' aren't listed as endangered, there is concern that populations are in decline and recent surveys confirm this. If numbers continue to fall this might lead to further loss of genetic diversity which could have an impact on future generations of weedy seadragons," she said.

Using the latest genomics (NGS, or next generation sequencing), the researchers identified four distinct genetic clusters - central NSW, southern NSW, Victoria and Tasmania. High-resolution images were also used to measure seadragon length and shape, revealing NSW individuals differed in a few measurements to those from Mornington Peninsula in Victoria.

The combined results suggest that not only are weedy seadragon populations significantly different along the east coast of Australia but that the Victorian weedy seadragons may form a subspecies.

"They are highly distinct to NSW and Tasmania and do not interbreed with any of the other populations. Biologists refer to this as being reproductively isolated.

"Because Victorian 'weedies' are the only animals used in the aquarium trade, worldwide, a bias towards this population exists in captivity. This has implications for conservation management," Dr Klanten said.

Co-author Professor David Booth, also of UTS Fish Ecology Lab, noted "as an ecologist it was clear to me that weedies from the populations were shaped differently and occupied different habitat types, but we were surprised how different they were genetically.

"Most global aquariums that exhibit weedies have sourced them from the Melbourne area, and this was quite distinct in our study, so we recommend extra care in managing the wild populations there," Professor Booth said.

The study sites were located in Sydney, Jervis Bay and Eden in NSW; Mornington Peninsula in Victoria; and Tasmania, and were surveyed over three years between 2016 and 2019. Sampling these masters of camouflage involved removing a small piece of tissue from their leaf-like appendages. Tissue samples were also taken from dead individuals washed up onshore and collected by citizen scientists.

Credit: 
University of Technology Sydney

New research highlights the importance of a forgotten organ in ensuring healthy pregnancies

An international research team led by the University of British Columbia (UBC) has uncovered for the first time the importance of a small gland tucked behind the sternum that works to prevent miscarriage and diabetes in pregnant women.

The organ in question is the thymus, identified in a study published today in the journal Nature as playing a significant role in both metabolic control and immunity in pregnancy.

How the immune system adapts to support mother and fetus has puzzled researchers for decades. The study--conducted by an international research team, including UBC's Dr. Josef Penninger--reveals an answer. The researchers have found that female sex hormones instruct important changes in the thymus, a central organ of the immune system, to produce specialized cells called Tregs to deal with physiological changes that arise in pregnancy.

The researchers also identified RANK, a receptor expressed in a part of the thymus called the epithelium, as the key molecule behind this mechanism.

"We knew RANK was expressed in the thymus, but its role in pregnancy was unknown," says the study's senior author Dr. Penninger, professor in the department of medical genetics and director of the Life Sciences Institute at UBC.

To get a better understanding, the authors studied mice where RANK had been deleted from the thymus.

"The absence of RANK prevented the production of Tregs in the thymus during pregnancy. That resulted in less Tregs in the placentas, leading to elevated rates of miscarriage," says the study's lead author Dr. Magdalena Paolino, assistant professor in the department of medicine at the Karolinska Institutet.

The findings also offer new molecular insights into the development of diabetes during pregnancy, known as gestational diabetes, a disease that affects approximately 15 percent of women in pregnancy worldwide, and about which scientists still know little.

In healthy pregnancies, the researchers found that Tregs migrated to the mother's fat tissue to prevent inflammation and help control glucose levels in the body. Pregnant mice lacking RANK had high levels of glucose and insulin in their blood and many other indicators of gestational diabetes, including larger-than-average young.

"Similar to babies of women with diabetes in pregnancy, the newborn pups were much heavier than average," says Dr. Paolino.

The deficiency of Tregs during pregnancy also resulted in long-lasting, transgenerational effects on the offspring. The pups remained prone to diabetes and overweight throughout their life spans. Giving the RANK-deficient mice thymus-derived Tregs isolated from normal pregnancies reversed all their health issues, including miscarriage and maternal glucose levels, and also normalized the body weights of the pups.

The researchers also analyzed women with diabetes in pregnancy, revealing a reduced number of Tregs in their placentas, similar to the study on mice.

"The discovery of this new mechanism underlying gestational diabetes potentially offers new therapeutic targets for mother and fetus in the future," says co-author Dr. Alexandra Kautzky-Willer, a clinician-researcher based at the Medical University of Vienna.

"The thymus changes massively during pregnancy and how such rewiring of an entire tissue contributes to a healthy pregnancy has been one of the remaining mysteries of immunology," adds Dr. Penninger. "Our work over many years has now not only solved this puzzle - pregnancy hormones rewire the thymus via RANK - but uncovered a new paradigm for its function: the thymus not only changes the immune system of the mother so it does not reject the fetus, but the thymus also controls metabolic health of the mother.

"This research changes our view of the thymus as an active and dynamic organ required to safeguard pregnancies," says Dr. Penninger.

Credit: 
University of British Columbia

The thymus as key to healthy pregnancies

image: The thymus as key to healthy pregnancies.

Image: 
@IMBA/Kulcsar

Female sex hormones instruct the thymus, a central organ of the immune system, to produce specialized cells called "Tregs" to deal with physiological changes to arise during pregnancy, the study revealed. The researchers also found that RANK, a receptor expressed in a part of the thymus called the epithelium, is the key molecule behind this mechanism. The study is an international research effort including scientists from IMBA, the University of British Columbia, the Karolinska Institutet and the Medical University of Vienna.

"We knew RANK was expressed in the thymus, but its role in pregnancy was unknown," says the study's senior author Josef Penninger, IMBA group leader and founding director, who is now director of the Life Sciences Institute of the University of British Columbia. To gain deeper insights, the authors studied mice where RANK had been deleted from the thymus. "The absence of RANK prevented the production of Tregs in the thymus during pregnancy. That resulted in less Tregs in the placentas, leading to elevated rates of miscarriage," says the study's lead author Magdalena Paolino, former postdoctoral fellow at IMBA, who now heads, since 2017, her own laboratory at the renowned Karolinska Institutet in Sweden.

The findings also offer new molecular insights into the development of gestational diabetes, a disease that affects approximately 15 percent of women in pregnancy worldwide, and yet still puzzles scientists to this day.

In healthy pregnancies, the researchers found that Tregs migrated to the mother's fat tissue to prevent inflammation and help control glucose levels in the body. Pregnant mice lacking RANK had high levels of glucose and insulin in their blood and many other indicators of gestational diabetes, including larger-than-average young. "Similar to babies of women with gestational diabetes, the newborn pups were much heavier than average," says Paolino.

The deficiency of Tregs during pregnancy in mothers also resulted in long-lasting transgenerational effects on the offspring, which remained prone to diabetes and overweight throughout their life spans. Interestingly, administering thymus-derived Tregs isolated from normal pregnancies to the RANK-deficient mice reversed all the mice's health issues, including miscarriage and maternal glucose levels, and also normalised the body weights of the pups.

The researchers also analysed women with gestational diabetes, revealing a reduced number of Tregs in their placentas, similar to the study on mice. "The discovery of this new mechanism underlying gestational diabetes potentially offers new therapeutic targets for mother and fetus in the future," says co-author Dr. Alexandra Kautzky-Willer, a clinician researcher based at the Medical University of Vienna.

"The thymus changes massively during pregnancy and how such rewiring of an entire tissue contributes to a healthy pregnancy has been one of the remaining mysteries of immunology," adds Dr. Penninger. "Our work over many years has now not only solved this puzzle - pregnancy hormones rewire the thymus via RANK - but uncovered a new paradigm for its function: the thymus not only changes the immune system of the mother so it does not reject the fetus, but the thymus also controls metabolic health of the mother." "This research changes our view of the thymus as an active and dynamic organ required to safeguard pregnancies," says Penninger.

The study was made possible thanks to a close collaboration between the Institute of Molecular Biotechnology of the Austrian Academy of Sciences in Vienna, the Life Sciences Institute in Vancouver, and the Karolinska Institutet. Researchers from the CeMM Institute and the Medical University in Vienna, as well as from the University of Birmingham and Oxford in the United Kingdom also participated.

Credit: 
IMBA- Institute of Molecular Biotechnology of the Austrian Academy of Sciences

Wistar reports new class of antibiotics active against a wide range of bacteria

image: Bacteria image

Image: 
The Wistar Institute

PHILADELPHIA -- (Dec. 23, 2020) -- Wistar Institute scientists have discovered a new class of compounds that uniquely combine direct antibiotic killing of pan drug-resistant bacterial pathogens with a simultaneous rapid immune response for combatting antimicrobial resistance (AMR). These finding were published today in Nature.

The World Health Organization (WHO) has declared AMR as one of the top 10 global public health threats against humanity. It is estimated that by 2050, antibiotic-resistant infections could claim 10 million lives each year and impose a cumulative $100 trillion burden on the global economy. The list of bacteria that are becoming resistant to treatment with all available antibiotic options is growing and few new drugs are in the pipeline, creating a pressing need for new classes of antibiotics to prevent public health crises.

"We took a creative, double-pronged strategy to develop new molecules that can kill difficult-to-treat infections while enhancing the natural host immune response," said Farokh Dotiwala, M.B.B.S., Ph.D., assistant professor in the Vaccine & Immunotherapy Center and lead author of the effort to identify a new generation of antimicrobials named dual-acting immuno-antibiotics (DAIAs).

Existing antibiotics target essential bacterial functions, including nucleic acid and protein synthesis, building of the cell membrane, and metabolic pathways. However, bacteria can acquire drug resistance by mutating the bacterial target the antibiotic is directed against, inactivating the drugs or pumping them out.

"We reasoned that harnessing the immune system to simultaneously attack bacteria on two different fronts makes it hard for them to develop resistance," said Dotiwala.

He and colleagues focused on a metabolic pathway that is essential for most bacteria but absent in humans, making it an ideal target for antibiotic development. This pathway, called methyl-D-erythritol phosphate (MEP) or non-mevalonate pathway, is responsible for biosynthesis of isoprenoids -- molecules required for cell survival in most pathogenic bacteria. The lab targeted the IspH enzyme, an essential enzyme in isoprenoid biosynthesis, as a way to block this pathway and kill the microbes. Given the broad presence of IspH in the bacterial world, this approach may target a wide range of bacteria.

Researchers used computer modeling to screen several million commercially available compounds for their ability to bind with the enzyme, and selected the most potent ones that inhibited IspH function as starting points for drug discovery.

Since previously available IspH inhibitors could not penetrate the bacterial cell wall, Dotiwala collaborated with Wistar's medicinal chemist Joseph Salvino, Ph.D., professor in The Wistar Institute Cancer Center and a co-senior author on the study, to identify and synthesize novel IspH inhibitor molecules that were able to get inside the bacteria.

The team demonstrated that the IspH inhibitors stimulated the immune system with more potent bacterial killing activity and specificity than current best-in-class antibiotics when tested in vitro on clinical isolates of antibiotic-resistant bacteria, including a wide range of pathogenic gram negative and gram positive bacteria. In preclinical models of gram negative bacterial infection, the bactericidal effects of the IspH inhibitors outperformed traditional pan antibiotics. All compounds tested were shown to be nontoxic to human cells.

"Immune activation represents the second line of attack of the DAIA strategy," said Kumar Singh, Ph.D., Dotiwala lab postdoctoral fellow and first author of the study.

"We believe this innovative DAIA strategy may represent a potential landmark in the world's fight against AMR, creating a synergy between the direct killing ability of antibiotics and the natural power of the immune system," echoed Dotiwala.

Credit: 
The Wistar Institute

How our brains track where we and others go

image: A wireless device records each patient's brain waves as he or she navigates an empty room.

Image: 
UCLA/Suthana lab

As COVID cases rise, physically distancing yourself from other people has never been more important. Now a new UCLA study reveals how your brain navigates places and monitors someone else in the same location.

Published Dec. 23 in Nature, the findings suggest that our brains generate a common code to mark where other people are in relation to ourselves.

"We studied how our brain reacts when we navigate a physical space - first alone and then with others," said senior author Nanthia Suthana, the Ruth and Raymond Stotter Chair in Neurosurgery and an assistant professor of neurosurgery and psychiatry at the David Geffen School of Medicine at UCLA and Jane and Terry Semel Institute for Neuroscience and Human Behavior.

"Our results imply that our brains create a universal signature to put ourselves in someone else's shoes," added Suthana, whose laboratory studies how the brain forms and recalls memories.

Suthana and her colleagues observed epilepsy patients whose brains had been surgically implanted earlier with electrodes to control their seizures. The electrodes resided in the medial temporal lobe, the brain center linked to memory and suspected to regulate navigation, much like a GPS device.

"Earlier studies have shown that low-frequency brain waves by neurons in the medial temporal lobe help rodents keep track of where they are as they navigate a new place," said first author Matthias Stangl, a postdoctoral scholar in Suthana's lab. "We wanted to investigate this idea in people--and test whether they could also monitor others near them--but were hampered by existing technology."

Using a $3.3 million award from the National Institutes of Health's BRAIN Initiative, Suthana's lab invented a special backpack containing a computer that wirelessly connects to brain electrodes. This enabled her to study research subjects as they moved freely instead of lying still in a brain scanner or hooked up to a recording device.

In this experiment, each patient wore the backpack and was instructed to explore an empty room, find a hidden spot and remember it for future searches. While they walked, the backpack recorded their brain waves, eye movements and paths through the room in real time.

As the participants searched the room, their brain waves flowed in a distinctive pattern, suggesting that each person's brain had mapped out the walls and other boundaries. Interestingly, the patients' brain waves also flowed in a similar manner when they sat in a corner of the room and watched someone else approach the location of the hidden spot.

The finding implies that our brains produce the same pattern to track where we and other people are in a shared environment.

Why is this important?

"Everyday activities require us to constantly navigate around other people in the same place," said Suthana, who is also an assistant professor of psychology at UCLA's College of Letters and Science and of bioengineering at the Henry Samueli School of Engineering. "Consider choosing the shortest airport security line, searching for a space in a crowded parking lot or avoiding bumping into someone on the dance floor."

In a secondary finding, the UCLA team discovered that what we pay attention to may influence how our brains map out a location. For example, the patients' brain waves flowed stronger when they searched for the hidden spot - or witnessed another person approach the location - than when they simply explored the room.

"Our results support the idea that, under certain mental states, this pattern of brain waves may help us recognize boundaries," said Stangl. "In this case, it was when people were focused on a goal and hunting for something."

Future studies will explore how people's brain patterns react in more complex social situations, including outside the laboratory. The UCLA team has made the backpack available to other researchers to accelerate discoveries about the brain and brain disorders.

Credit: 
University of California - Los Angeles Health Sciences

Ancient DNA retells story of Caribbean's first people, with a few plot twists

image: Archaeological research and ancient DNA technology can work hand in hand to illuminate past history. This vessel, made between AD 1200-1500 in present-day Dominican Republic, shows a frog figure, associated with the goddess of fertility in Taino culture.

Image: 
Kristen Grace/Florida Museum

GAINESVILLE, Fla. --- The history of the Caribbean's original islanders comes into sharper focus in a new Nature study that combines decades of archaeological work with advancements in genetic technology.

An international team led by Harvard Medical School's David Reich analyzed the genomes of 263 individuals in the largest study of ancient human DNA in the Americas to date. The genetics trace two major migratory waves in the Caribbean by two distinct groups, thousands of years apart, revealing an archipelago settled by highly mobile people, with distant relatives often living on different islands.

Reich's lab also developed a new genetic technique for estimating past population size, showing the number of people living in the Caribbean when Europeans arrived was far smaller than previously thought - likely in the tens of thousands, rather than the million or more reported by Columbus and his successors.

For archaeologist William Keegan, whose work in the Caribbean spans more than 40 years, ancient DNA offers a powerful new tool to help resolve longstanding debates, confirm hypotheses and spotlight remaining mysteries.

This "moves our understanding of the Caribbean forward dramatically in one fell swoop," said Keegan, curator at the Florida Museum of Natural History and co-senior author of the study. "The methods David's team developed helped address questions I didn't even know we could address."

Archaeologists often rely on the remnants of domestic life - pottery, tools, bone and shell discards - to piece together the past. Now, technological breakthroughs in the study of ancient DNA are shedding new light on the movement of animals and humans, particularly in the Caribbean where each island can be a unique microcosm of life.

While the heat and humidity of the tropics can quickly break down organic matter, the human body contains a lockbox of genetic material: a small, unusually dense part of the bone protecting the inner ear. Primarily using this structure, researchers extracted and analyzed DNA from 174 people who lived in the Caribbean and Venezuela between 400 and 3,100 years ago, combining the data with 89 previously sequenced individuals.

The team, which includes Caribbean-based scholars, received permission to carry out the genetic analysis from local governments and cultural institutions that acted as caretakers for the human remains. The authors also engaged representatives of Caribbean Indigenous communities in a discussion of their findings.

The genetic evidence offers new insights into the peopling of the Caribbean. The islands' first inhabitants, a group of stone tool-users, boated to Cuba about 6,000 years ago, gradually expanding eastward to other islands during the region's Archaic Age. Where they came from remains unclear - while they are more closely related to Central and South Americans than to North Americans, their genetics do not match any particular Indigenous group. However, similar artifacts found in Belize and Cuba may suggest a Central American origin, Keegan said.

About 2,500-3,000 years ago, farmers and potters related to the Arawak-speakers of northeast South America established a second pathway into the Caribbean. Using the fingers of South America's Orinoco River Basin like highways, they travelled from the interior to coastal Venezuela and pushed north into the Caribbean Sea, settling Puerto Rico and eventually moving westward. Their arrival ushered in the region's Ceramic Age, marked by agriculture and the widespread production and use of pottery.

Over time, nearly all genetic traces of Archaic Age people vanished, except for a holdout community in western Cuba that persisted as late as European arrival. Intermarriage between the two groups was rare, with only three individuals in the study showing mixed ancestry.

Many present-day Cubans, Dominicans and Puerto Ricans are the descendants of Ceramic Age people, as well as European immigrants and enslaved Africans. But researchers noted only marginal evidence of Archaic Age ancestry in modern individuals.

"That's a big mystery," Keegan said. "For Cuba, it's especially curious that we don't see more Archaic ancestry."

During the Ceramic Age, Caribbean pottery underwent at least five marked shifts in style over 2,000 years. Ornate red pottery decorated with white painted designs gave way to simple, buff-colored vessels, while other pots were punctuated with tiny dots and incisions or bore sculpted animal faces that likely doubled as handles. Some archaeologists pointed to these transitions as evidence for new migrations to the islands. But DNA tells a different story, suggesting all of the styles were developed by descendants of the people who arrived in the Caribbean 2,500-3,000 years ago, though they may have interacted with and took inspiration from outsiders.

"That was a question we might not have known to ask had we not had an archaeological expert on our team," said co-first author Kendra Sirak, a postdoctoral fellow in the Reich Lab. "We document this remarkable genetic continuity across changes in ceramic style. We talk about 'pots vs. people,' and to our knowledge, it's just pots."

Highlighting the region's interconnectivity, a study of male X chromosomes uncovered 19 pairs of "genetic cousins" living on different islands - people who share the same amount of DNA as biological cousins but may be separated by generations. In the most striking example, one man was buried in the Bahamas while his relative was laid to rest about 600 miles away in the Dominican Republic.

"Showing relationships across different islands is really an amazing step forward," said Keegan, who added that shifting winds and currents can make passage between islands difficult. "I was really surprised to see these cousin pairings between islands."

Uncovering such a high proportion of genetic cousins in a sample of fewer than 100 men is another indicator that the region's total population size was small, said Reich, professor of genetics in the Blavatnik Institute at HMS and professor of human evolutionary biology at Harvard.

"When you sample two modern individuals, you don't often find that they're close relatives," he said. "Here, we're finding relatives all over the place."

A technique developed by study co-author Harald Ringbauer, a postdoctoral fellow in the Reich Lab, used shared segments of DNA to estimate past population size, a method that could also be applied to future studies of ancient people. Ringbauer's technique showed about 10,000 to 50,000 people were living on two of the Caribbean's largest islands, Hispaniola and Puerto Rico, shortly before European arrival. This falls far short of the million inhabitants Columbus described to his patrons, likely to impress them, Keegan said.

Later, 16th-century historian Bartolomé de las Casas claimed the region had been home to 3 million people before being decimated by European enslavement and disease. While this, too, was an exaggeration, the number of people who died as a result of colonization remains an atrocity, Reich said.

"This was a systematic program of cultural erasure. The fact that the number was not 1 million or millions of people, but rather tens of thousands, does not make that erasure any less significant," he said.

For Keegan, collaborating with geneticists gave him the ability to prove some hypotheses he had argued for years - while upending others.

"At this point, I don't care if I'm wrong or right," he said. "It's just exciting to have a firmer basis for reevaluating how we look at the past in the Caribbean. One of the most significant outcomes of this study is that it demonstrates just how important culture is in understanding human societies. Genes may be discrete, measurable units, but the human genome is culturally created."

Credit: 
Florida Museum of Natural History

Disposable surgical masks best for being heard clearly when speaking, study finds

image: Masks are an important tool for fighting COVID-19 but wearing one can make it difficult for others to hear us speak. Using a unique laboratory setup, Illinois researcher Ryan Corey tested how different types of masks affect the acoustics of speech.

Image: 
Photo courtesy Ryan Corey

CHAMPAIGN, Ill. -- Researcher Ryan Corey recently heard from a friend who teaches at a school where some of the students have hearing loss. The friend wanted to know if he had any ideas to help her communicate with these students while wearing a mask to slow the spread of COVID-19. Corey, who also has hearing loss, did not know what to tell her. So, he headed to the Illinois Augmented Listening Laboratory to look for solutions.

Corey, an electrical and computer engineering postdoctoral researcher under professor Andrew Singer at the University of Illinois Urbana-Champaign, leads a team that studies audio signal processing, especially for listening devices like hearing aids. The results of the team's new study evaluating the acoustic effects of face masks on speech are published in The Journal of the Acoustical Society of America.

To see a video explaining this research, click here.

"Previous research performed on this subject has focused on medical masks worn in health care settings," Corey said, "But no one has looked at the acoustic effects caused by different kinds of fabric masks, so that's where I focused our study."

The team tested medical masks, disposable surgical masks, masks with clear plastic windows around the mouth, and homemade and store-bought cloth masks made of different fabric types and numbers of layers.

The researchers used a special loudspeaker, custom built by School of Art and Design graduate Uriah Jones and shaped like a human head so that sound radiates as it would coming from a human mouth.

"We put the different masks onto the head-shaped loudspeaker and played the same sound for every test," Corey said. "We also placed the speaker onto a turntable to add a directional component to our data."

The team collected data from a mask-wearing human speaker, as well.

"Using a real person makes the sounds less repeatable because we can't say the same thing the same way every time. However, it does let us account for the real shape of the head and real movements of lips," Corey said. "Even though these two data sets are a bit different, they both show which sound frequencies are most affected by mask-wearing and which masks have the strongest effects."

Their data showed that all masks muffle the quiet, high-frequency sound generated when a person pronounces consonants. "Those sounds are already a challenge for those with hearing loss, with or without masks, and even become a challenge for those without hearing loss when you throw a mask into the mix."

Masks also block visual cues like facial expression and lip motion, so speech reading is no longer an option when wearing most masks. Almost everyone uses speech reading to some extent, with or without hearing loss, Corey said.

"That's why we tested the clear-window masks that have become very popular," he said. "Unfortunately, the trade-off is that you can see through them, but they block the most sound of all the masks we tested."

The study found that disposable surgical masks offer the best acoustic performance among all tested, Corey said. Loosely woven 100% cotton masks also perform well but, as shown in a study by other Illinois researchers, they may not be as effective as surgical masks at blocking respiratory droplets. That study showed that tightly woven cotton and blended fabrics may block more droplets, but Corey's team found that they also block more sound. Based on the droplet study, Corey suggested that multilayer masks made of loosely woven cotton may offer a reasonable compromise between droplet-blocking efficiency and acoustic performance.

The good news is that most masks do not completely block sound, they simply deflect it away from the mouth. This detail means that simple amplification devices can make masked speech more accessible to everyone. In particular, the lapel microphones that are already used in many classrooms and lecture halls are only mildly affected by face masks. Many hearing aids support remote microphone accessories that are also worn near the lapel.

"Most people do not walk around with lapel mics and amplification systems while wearing a mask, but it can help in settings where it does make sense, like classrooms and meetings," Corey said.

Credit: 
University of Illinois at Urbana-Champaign, News Bureau